Rapid Therapeutic Science Laboratories, Inc. (RTSL)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.15 Million | -2.2 Million | -106.66 Thousand | -129.85 Thousand | -21.84 Thousand | -10.74 Thousand |
| Net Income | -1.79 Million | -2.86 Million | -348.84 Thousand | -2.55 Million | -21.61 Thousand | -12.02 Thousand |
| Depreciation & Amortization | 23.97 Thousand | 55.85 Thousand | 37.5 Thousand | 16.39 Thousand | - | - |
| Deferred income taxes | - | -631.85 Thousand | 7425.00 | - | - | - |
| Stock-based compensation | 20 Thousand | 20 Thousand | 43 Thousand | 7167.00 | - | - |
| Change in working capital | 200.04 Thousand | 66.88 Thousand | 199.17 Thousand | 29.31 Thousand | -227.00 | 1277.00 |
| Other non-cash items | 399 Thousand | 1.14 Million | -44.92 Thousand | 2.37 Million | - | - |
| Investing Cash Flow | -39.15 Thousand | -292.53 Thousand | -155.07 Thousand | -38.62 Thousand | - | - |
| Investments in PPE | -39.15 Thousand | -292.53 Thousand | -155.07 Thousand | -38.62 Thousand | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 998.38 Thousand | 2.19 Million | 95.7 Thousand | 173.37 Thousand | 20 Thousand | 10 Thousand |
| Debt repayment | -287.9 Thousand | 1.61 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 585 Thousand | 75 Thousand | 1000.00 | - | - |
| Other Financing Activities | 1.28 Million | - | 20.7 Thousand | 172.37 Thousand | 20 Thousand | 10 Thousand |
| Accounts receivables | - | - | 5873.00 | - | - | - |
| Accounts payables | 127.51 Thousand | 82.18 Thousand | 4702.00 | 14.65 Thousand | -977.00 | 1277.00 |
| Inventory | - | 11.75 Thousand | -5873.00 | - | - | - |
| Other working capital | 72.52 Thousand | -27.05 Thousand | 194.47 Thousand | 14.66 Thousand | 750.00 | - |
| Cash at beginning of period | 192.48 Thousand | 499.14 Thousand | 12.29 Thousand | 7395.00 | 9238.00 | 9981.00 |
| Cash at end of period | - | 192.48 Thousand | 1334.00 | 12.29 Thousand | 7395.00 | 9238.00 |
| Capital Expenditure | -39.15 Thousand | -292.53 Thousand | -155.07 Thousand | -38.62 Thousand | - | - |
| Effect of forex changes on cash | - | - | 155.07 Thousand | - | - | - |
| Net cash flow / Change in cash | -192.48 Thousand | -306.66 Thousand | -10.96 Thousand | 4902.00 | -1843.00 | -743.00 |
| Free Cash Flow | -1.19 Million | -2.5 Million | -261.73 Thousand | -168.47 Thousand | -21.84 Thousand | -10.74 Thousand |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 46.42 Thousand | 191.27 Thousand | -1.79 Million | 48.93 Thousand | -227.07 Thousand | -36.83 Thousand |
| Depreciation & Amortization | 48.51 Thousand | 5993.00 | 23.97 Thousand | -57.78 Thousand | 27.25 Thousand | 27.25 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 20 Thousand | -118.42 Thousand | 59.21 Thousand | 59.21 Thousand |
| Change in working capital | -63.94 Thousand | 79.3 Thousand | 200.04 Thousand | -255.33 Thousand | 168.84 Thousand | -158.1 Thousand |
| Other non-cash items | -38.31 Thousand | -318.38 Thousand | 399 Thousand | 30.54 Thousand | -193.64 Thousand | -141.99 Thousand |
| Investing Cash Flow | - | -210.43 Thousand | -39.15 Thousand | 315.64 Thousand | -1.00 | -3949.00 |
| Investments in PPE | - | -210.43 Thousand | -39.15 Thousand | -39.15 Thousand | -1.00 | -3949.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 354.8 Thousand | - | - |
| Financing Cash Flow | -8087.00 | 59.38 Thousand | 998.38 Thousand | 36.4 Thousand | 53.25 Thousand | 333.6 Thousand |
| Debt repayment | -14.5 Thousand | -24.2 Thousand | -287.9 Thousand | -189.4 Thousand | -59.1 Thousand | -39.4 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 6413.00 | 83.58 Thousand | 1.28 Million | 225.8 Thousand | 112.35 Thousand | 373 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 14.89 Thousand | 33.88 Thousand | 127.51 Thousand | -270.7 Thousand | 153.56 Thousand | -181.85 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -78.83 Thousand | 45.42 Thousand | 72.52 Thousand | 15.37 Thousand | 15.28 Thousand | 23.75 Thousand |
| Cash at beginning of period | 17.57 Thousand | 210.43 Thousand | 192.48 Thousand | - | 112.16 Thousand | 32.98 Thousand |
| Cash at end of period | 2160.00 | 17.57 Thousand | - | - | - | 112.16 Thousand |
| Capital Expenditure | - | -210.43 Thousand | -39.15 Thousand | -39.15 Thousand | -1.00 | -3949.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -15.41 Thousand | -192.85 Thousand | -192.48 Thousand | - | -112.16 Thousand | 79.17 Thousand |
| Free Cash Flow | -7325.00 | -252.24 Thousand | -1.19 Million | -391.2 Thousand | -165.41 Thousand | -254.42 Thousand |
600697
601669
ALREW
PRO
QVCC
LVRO